Ventilator Associated Pneumonia: Clinical Trials

12 trials for Ventilator Associated Pneumonia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 not yet recruiting, 1 recruiting, 1 terminated. 12 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 412Completed 7, Not yet recruiting 1, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1

Follow Ventilator Associated Pneumonia: new trials by email Literature Review of Ventilator Associated Pneumonia trials Research Report on Ventilator Associated Pneumonia

Trials (filtered) newest first · largest first

All 12 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prevention of Infection of the Respiratory Tract Through Application of Non-Invasive Methods of Secretion Suctioning
airway clearance, subglottic secretion aspiration, Ceftriaxone 2 grams daily - Intubation Complication, Stroke, Ischemic
Phase 4Not yet recruitingHospital San Carlos, Madrid602026-09-152026-08-06
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
Rapid Diagnostics - Blood Stream Infections, Ventilator Associated Pneumonia
Phase 4RecruitingNational University of Singapore15262023-12-122026-10-22
The Duration of Antibiotic Therapy for Early (DATE) Ventilator Associated Pneumonia (VAP): 4 vs. 7 Days
Standard of Care Antibiotic Therapy - Ventilator Associated Pneumonia
Phase 4TerminatedUniversity of Miami272023-05-082026-01-16
GRam Stain-guided Antibiotics ChoicE for Ventilator-Associated Pneumonia (GRACE-VAP) Trial
Gram stain-guided antibiotic choice, Guidelines-based antibiotics choice - Ventilator Associated Pneumonia
Phase 4CompletedOsaka General Medical Center2062018-04-012022-09-21
Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial
L. rhamnosus GG - Probiotic, Placebo - Microcrystalline Cellulose - Ventilator Associated Pneumonia, Infections
Phase 4CompletedMcMaster University26502015-06-012020-12-17
Common Canister Protocol for Inhaler Administration in Mechanically Ventilated Patients
Common canister - Ventilator Associated Pneumonia
Phase 4CompletedBarnes-Jewish Hospital3542013-06-012016-10-07
Ventilator Associated Pneumonia in Taper Guard Versus Normal Tube in ICU Patients
Taper Guard Endotracheal Tube, Conventional endotracheal tube - Ventilator Associated Pneumonia
Phase 4UnknownUniversity of Malaya1002012-02-012011-12-29
Pharmacodynamics Study of Imipenem in Patients With Ventilator Associated Pneumonia
Imipenem - Ventilator Associated Pneumonia
Phase 4CompletedPrince of Songkla University82011-11-012017-09-20
Antibiotic Prophylaxis for Early Ventilator-associated Pneumonia in Neurological Patients
Sultamicillin - Ventilator Associated Pneumonia
Phase 4WithdrawnHospital Pablo Tobón Uribe2011-03-012016-05-24
Toothbrushing and Ventilator-associated Pneumonia
Toothbrushing with a manual brush - Ventilator Associated Pneumonia
Phase 4CompletedHospital Universitario de Canarias4362010-08-012011-11-22
A Clinico-Bacteriological Study and Effect of Stress Ulcer Prophylaxis on Occurrence of Ventilator Associated Pneumonia
Ranitidine, Sucralfate - Ventilator Associated Pneumonia, Etiological Organisms
Phase 4CompletedMaulana Azad Medical College502005-03-012008-06-20
Intravenous Clarithromycin in Septic Syndrome
Intravenous Clarithromycin - Sepsis, Ventilator Associated Pneumonia
Phase 4CompletedUniversity of Athens2002004-06-012006-02-28

Narrower conditions

Pneumonia, Ventilator-Associated (12)  ·  Cross Infection (2)  ·  Sepsis (2)  ·  Asthma (1)  ·  Brain Injuries (1)  ·  Coma (1)  ·  Craniocerebral Trauma (1)  ·  Diarrhea (1)  ·  Healthcare-Associated Pneumonia (1)  ·  Heart Arrest (1)  ·  Hemorrhagic Stroke (1)  ·  Infections (1)  ·  Ischemic Stroke (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Broader conditions

Disease Attributes (12)  ·  Iatrogenic Disease (12)  ·  Lung Diseases (12)  ·  Pathologic Processes (12)  ·  Pathological Conditions, Signs and Symptoms (12)  ·  Pneumonia (12)  ·  Respiratory Tract Diseases (12)  ·  Respiratory Tract Infections (12)  ·  Healthcare-Associated Pneumonia (11)  ·  Infections (11)  ·  Cross Infection (10)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Inflammation (2)  ·  Nervous System Diseases (2)

Interventions

Cilastatin, Imipenem Drug Combination (1)  ·  Imipenem (1)  ·  Ranitidine (1)  ·  Rapid Diagnostic Tests (1)  ·  Sucralfate (1)  ·  Toothbrushing (1)  ·  sultamicillin (1)

Sponsors

Barnes-Jewish Hospital (1)  ·  Hospital Pablo Tobón Uribe (1)  ·  Hospital San Carlos, Madrid (1)  ·  Hospital Universitario de Canarias (1)  ·  Maulana Azad Medical College (1)  ·  McMaster University (1)  ·  National University of Singapore (1)  ·  Osaka General Medical Center (1)  ·  Prince of Songkla University (1)  ·  University of Athens (1)  ·  University of Malaya (1)  ·  University of Miami (1)

Countries

United States (3)  ·  India (2)  ·  Malaysia (2)  ·  Spain (2)  ·  Thailand (2)  ·  Canada (1)  ·  Colombia (1)  ·  Greece (1)  ·  Japan (1)  ·  Saudi Arabia (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)

Top investigators

Apostolos Armaganidis, MD, PhD (1)  ·  Carlos A Cadavid, MD (1)  ·  Charis Roussos, MD, PhD (1)  ·  David Paterson, Professor (1)  ·  Deborah J Cook, MD (1)  ·  Evangelos J Giamarellos-Bourboulis, MD, PhD (1)  ·  Foong-Ming Moy, BSc, MSc, MMedSc PH, PhD (1)  ·  Helen Giamarellou, MD, PhD (1)  ·  Jonathan Meizoso, MD, MSPH (1)  ·  Jumpei Yoshimura, MD (1)  ·  Kang-Kwong Wong, MBBS;MAnesth (1)  ·  Kazuma Yamakawa, MD, PhD (1)  ·  Leonardo Lorente, Medical (1)  ·  Manuel Alvarez-Gonzalez, MD.PhD (1)  ·  Marin Kollef, MD (1)

Results publications

PMID 11778260, PMID 11888973, PMID 17872488, PMID 18707849, PMID 21478738, PMID 22422274, PMID 27044546, PMID 27143787, PMID 29741298, PMID 30409160, PMID 31227528, PMID 31783881, PMID 34546300, PMID 34871241, PMID 35394515, PMID 35724443, PMID 36682909, PMID 39731129, PMID 41013603, PMID 41248372

NIH funding

2025 (1)